Insulin aspart and insulin degludec Subcutaneous and VePesid
Determining the interaction of Insulin aspart and insulin degludec Subcutaneous and VePesid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin degludec
Brand name: Ryzodeg 70/30 FlexTouch
Synonyms: Insulin aspart and insulin degludec (Subcutaneous)
Generic Name: etoposide
Brand name: VePesid, Etopophos, Toposar
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart and insulin degludec Subcutaneous-Vepesid Oral
- Insulin aspart and insulin degludec Subcutaneous-Veramyst
- Insulin aspart and insulin degludec Subcutaneous-Veramyst Nasal
- Insulin aspart and insulin degludec Subcutaneous-Verapamil
- Insulin aspart and insulin degludec Subcutaneous-Verapamil Extended Release Capsules
- Insulin aspart and insulin degludec Subcutaneous-Verapamil Extended Release Tablets
- VePesid-Insulin Aspart Injection
- VePesid-Insulin Aspart Protamine and Insulin Aspart
- VePesid-Insulin aspart protamine and insulin aspart Subcutaneous
- VePesid-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- VePesid-Insulin Aspart Protamine and Insulin Aspart (Vials)
- VePesid-Insulin Aspart Protamine Injection